Barugola, G
23  results:
Search for persons X
?
1

P1033 Road to exit strategy in patients with inflammatory b..:

Todeschini, A ; Ciccocioppo, R ; Geccherle, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1863-i1863 , 2024
 
?
3

P893 Transition from intravenous to subcutaneous infliximab..:

Todeschini, A ; Geccherle, A ; Signoretto, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1641-i1641 , 2024
 
?
4

P532 The enhanced recovery after surgery protocol take its ..:

Barugola, G ; Bertocchi, E ; Masini, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1047-i1047 , 2024
 
?
5

P344 Diverting ileostomy in Inflammatory Bowel Disease's su..:

Ascari, F ; Barugola, G ; Ruffo, G
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i481-i483 , 2023
 
?
 
?
9

P125 Role of UCEIS vs. MES in predicting patients unrespons..:

Variola, A ; Di Ruscio, M ; Barugola, G...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S150-S151 , 2019
 
?
10

P.15.10 ENDOSCOPIC TREATMENT OF ANASTOMOTIC STENOSIS AFTER ..:

Orlandi, S. ; Variola, A. ; Benini, M....
Digestive and Liver Disease.  48 (2016)  - p. e204-e205 , 2016
 
?
 
?
 
?
14

Is CA 19-9 a screening marker?:

Barugola, G. ; Frulloni, L. ; Salvia, R..
Digestive and Liver Disease.  41 (2009)  5 - p. 325-327 , 2009
 
?
15

High complication rate in Crohn's disease surgery following..:

Celentano V ; Pellino G ; Rottoli M...
info:eu-repo/semantics/altIdentifier/pmid/35599268.  , 2022
 
1-15